BNP Paribas Financial Markets Boosts Stake in The Joint Corp. (NASDAQ:JYNT)

BNP Paribas Financial Markets lifted its holdings in shares of The Joint Corp. (NASDAQ:JYNT) by 5.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,510 shares of the company’s stock after purchasing an additional 1,156 shares during the quarter. BNP Paribas Financial Markets’ holdings in Joint were worth $258,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Los Angeles Capital Management LLC acquired a new position in Joint during the second quarter worth $1,115,000. Clayton Partners LLC lifted its stake in Joint by 38.1% during the 2nd quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock worth $2,622,000 after acquiring an additional 51,500 shares in the last quarter. Renaissance Technologies LLC grew its position in Joint by 5.5% in the 2nd quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock valued at $5,546,000 after acquiring an additional 20,400 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Joint by 9.8% during the second quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company’s stock worth $2,730,000 after purchasing an additional 17,268 shares during the period. Finally, XTX Topco Ltd purchased a new stake in Joint during the second quarter worth about $174,000. 76.88% of the stock is owned by institutional investors and hedge funds.

Joint Stock Performance

Shares of JYNT opened at $11.11 on Tuesday. The Joint Corp. has a 1 year low of $8.88 and a 1 year high of $17.82. The stock has a market capitalization of $166.47 million, a PE ratio of -9.75 and a beta of 1.57. The stock has a 50-day simple moving average of $11.35 and a 200-day simple moving average of $12.27.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. StockNews.com upgraded shares of Joint from a “hold” rating to a “buy” rating in a report on Friday, November 15th. Roth Mkm dropped their price target on shares of Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, November 8th.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.